Doxorubicin was intercalated into novel zirconium phosphate nano-platelets (ZrP). The obtained doxorubicin intercalated ZrP nano-platelets had an impressive 34.9% (w/w) drug loading. We used this material to deliver doxorubicin to breast cancer cells (MCF-7). Cellular studies with MCF-7 cells showed higher uptake and cytotoxicity of doxorubicin loaded ZrP compared to free doxorubicin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c2cc16218k | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!